Search Results for: OCONMED

Startup investment – to 21/7/24

CTERA raised $80 million; CytoReason raised $80 million; OCON Therapeutics raised $10 million; HAGAR raised $5 million (total $25 million); Acculine raised $4.2 million; Upword raised $3 million;

Posted in Economy & Business | Leave a comment

Treating intrauterine conditions

Israel’s OCON Healthcare (OCON Therapeutics) has been awarded $13 million of orders for its Intra Uterine Ball (IUB) proprietary platform. The purchasers are South America’s DKT and UK’s Consilient Healthcare, where the product will be fully reimbursed by the National … Continue reading

Posted in Israel's Medical Achievements | Leave a comment